X0202 SCHEDULE 13G 0001531964 XXXXXXXX LIVE Common Stock, $0.000001 par value 04/09/2026 0001487197 Barfresh Food Group Inc. 067532200 3600 Wilshire Boulevard Suite 1720 Los Angeles CA 90010 Rule 13d-1(c) Ibex Investors LLC b CO 1110982.00 0.00 1110982.00 0.00 1110982.00 N 7.0 OO limited liability company Justin B. Borus b X1 1440885.00 0.00 1440885.00 0.00 1440885.00 N 9.0 IN Ibex Microcap Fund LLLP b DE 1110982.00 0.00 1110982.00 0.00 1110982.00 N 7.0 PN Ibex Investment Holdings LLC b DE 1110982.00 0.00 1110982.00 0.00 1110982.00 N 7.0 OO limited liability company Barfresh Food Group Inc. 3600 Wilshire Boulevard Suite 1720 Los Angeles, CA, 90010 This Schedule 13G is filed by the following (the "Reporting Persons"): (1) Ibex Investors LLC, a Colorado limited liability company (the "Investment Manager"); (2) Justin B. Borus ; (3) Ibex Microcap Fund LLLP (the "Fund"); and (4) Ibex Investment Holdings LLC, a Delaware limited liability company ("IM Holdings") (all of the foregoing, collectively, the "Reporting Persons"). The Fund is a private investment vehicle. The Fund directly beneficially owns the Common Stock reported in this Statement (other than 329,903 shares of Common Stock directly beneficially owned by Justin B. Borus). The Investment Manager is the investment manager and general partner of the Fund. IM Holdings is the sole member of the Investment Manager. Justin B. Borus is the manager of IM Holdings and the Investment Manager. IM Holdings, the Investment Manager, and Justin B. Borus may be deemed to beneficially own the Common Stock directly beneficially owned by the Fund. Each Reporting Person disclaims beneficial ownership with respect to any shares other than the shares directly beneficially owned by such Reporting Person. The principal business office of the Reporting Person is c/o Ibex Investors LLC, 101 S Madison St, Denver, CO 80209. For citizenship information or place of organization see Item 4 of the cover page of each Reporting Person. Y See Item 9 on the cover page for each Reporting Person, and Item 2, which information is given as of the end of business on the Event Date of April 9, 2026. See Item 11 on the cover page for each Reporting Person. The foregoing percentages set forth in this response are based on 15,969,281 shares of Common Stock outstanding as of November 4, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 6, 2025. See Item 5 on the cover page for each Reporting Person. See Item 6 on the cover page for each Reporting Person. See Item 7 on the cover page for each Reporting Person. See Item 8 on the cover page for each Reporting Person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 - Joint Filing Agreement Ibex Investors LLC /s/ Justin B. Borus 04/09/2026 Justin B. Borus /s/ Justin B. Borus 04/09/2026 Ibex Microcap Fund LLLP /s/ Justin B. Borus 04/09/2026 Ibex Investment Holdings LLC /s/ Justin B. Borus 04/09/2026